Author Index: W
• SIDE EFFECT PERCEPTIONS AND THEIR EFFECT ON TREATMENT DECISIONS: A PSYCHOMETRIC INVESTIGATION
• RACIAL DISPARITIES ON EXPENDITURES OF PRESCRIPTION MEDICATION FOR MAJOR CHRONIC DISEASES IN THE U.S.: MEDICAL EXPENDITURE PANEL SURVEY 2011-2012
• PANEL: WHAT IS A "GOOD" MEDICAL DECISION? PERSPECTIVES FROM MULTIPLE STAKEHOLDERS: A SBM-SMDM CROSSTALK PANEL DISCUSSION
• �IT SOUNDS LIKE SOME BS�: ACCEPTANCE AND REJECTION OF GENETIC RISK COMMUNICATION
• RACIAL DISPARITIES ON EXPENDITURES OF PRESCRIPTION MEDICATION FOR MAJOR CHRONIC DISEASES IN THE U.S.: MEDICAL EXPENDITURE PANEL SURVEY 2011-2012
• PANEL: WHAT IS A "GOOD" MEDICAL DECISION? PERSPECTIVES FROM MULTIPLE STAKEHOLDERS: A SBM-SMDM CROSSTALK PANEL DISCUSSION
• �IT SOUNDS LIKE SOME BS�: ACCEPTANCE AND REJECTION OF GENETIC RISK COMMUNICATION
• INCREASING PATIENT CENTERED COMMUNICATION AND DECISION MAKING IN PRIMARY CARE OFFICE VISITS: COMPARATIVE EFFECTIVENESS OF A NOVEL MULTIDIMENSIONAL INTERVENTION WITH AN EXISTING PATIENT ACTIVATION INTERVENTION
• USING THE OBSERVER OPTION5 MEASURE TO EVALUATE THE EFFECT OF A NOVEL �OPEN COMMUNICATION� INTERVENTION ON SHARED DECISION-MAKING IN PRIMARY CARE APPOINTMENTS
• USING THE OBSERVER OPTION5 MEASURE TO EVALUATE THE EFFECT OF A NOVEL �OPEN COMMUNICATION� INTERVENTION ON SHARED DECISION-MAKING IN PRIMARY CARE APPOINTMENTS
• COST-EFFECTIVENESS OF ANTIPLATELET DRUGS AFTER PERCUTANEOUS CORONARY INTERVENTION
• COMPARATIVE EFFECTIVENESS AND COST EFFECTIVENESS OF GENERIC ALENDRONATE, RISEDRONATE, DENOSUMAB AND ZOLEDRONIC ACID FOR SECONDARY PREVENTION OF FRAGILITY FRACTURES- PRELIMINARY RESULTS
• ECONOMIC EVALUATION OF COMBINATION TREATMENTS � DOES USE OF NETWORK META-ANALYSIS MAKE A DIFFERENCE?
• COMPARATIVE EFFECTIVENESS AND COST EFFECTIVENESS OF GENERIC ALENDRONATE, RISEDRONATE, DENOSUMAB AND ZOLEDRONIC ACID FOR SECONDARY PREVENTION OF FRAGILITY FRACTURES- PRELIMINARY RESULTS
• ECONOMIC EVALUATION OF COMBINATION TREATMENTS � DOES USE OF NETWORK META-ANALYSIS MAKE A DIFFERENCE?
• BLOCK IT OUT! PRESENTING TEST RESULTS WITH CLEARLY DEFINED CATEGORIES INCREASES UNDERSTANDING OF THE RESULTS
• PRACTICE MAKES PERFECT: A PRACTICE TRAVEL DECISION INCREASES CONFIDENCE IN A SUBSEQUENT MEDICAL DECISION
• DO PRIMARY CARE CLINICIANS ASK PATIENTS WHAT MATTERS TO THEM? AN OBSERVATIONAL STUDY IN 5 FAMILY MEDICINE CLINICS
• ENGAGING PATIENTS AND OTHER STAKEHOLDERS IN THE DEVELOPMENT OF PATIENT DECISION AIDS: COMPARISONS OF CURRENT PRACTICES WITH USER-CENTERED DESIGN
• ENGAGEMENT OF MEMBERS OF MARGINALIZED POPULATIONS IN THE DEVELOPMENT OF PATIENT DECISION AIDS AND OTHER PATIENT-CENTERED TOOLS
• TEST RESULTS IN LINE GRAPHS INSTEAD OF TABLES: LESS CONFUSION WITHOUT DISTORTION
• PRACTICE MAKES PERFECT: A PRACTICE TRAVEL DECISION INCREASES CONFIDENCE IN A SUBSEQUENT MEDICAL DECISION
• DO PRIMARY CARE CLINICIANS ASK PATIENTS WHAT MATTERS TO THEM? AN OBSERVATIONAL STUDY IN 5 FAMILY MEDICINE CLINICS
• ENGAGING PATIENTS AND OTHER STAKEHOLDERS IN THE DEVELOPMENT OF PATIENT DECISION AIDS: COMPARISONS OF CURRENT PRACTICES WITH USER-CENTERED DESIGN
• ENGAGEMENT OF MEMBERS OF MARGINALIZED POPULATIONS IN THE DEVELOPMENT OF PATIENT DECISION AIDS AND OTHER PATIENT-CENTERED TOOLS
• TEST RESULTS IN LINE GRAPHS INSTEAD OF TABLES: LESS CONFUSION WITHOUT DISTORTION
• STRATIFIED MEDICINE AND COST-EFFECTIVENESS: STRONG INFLUENCE OF CHOICES IN MODELLING SHORT-TERM, TRIAL-BASED, MORTALITY RISK REDUCTION AND POST-TRIAL LIFE EXPECTANCY
• VARIABLE SELECTION FOR PROPENSITY SCORE MODELS IN COMPARATIVE EFFECTIVENESS RESEARCH ON CHRONIC CORONARY ARTERY DISEASE
• VALUE OF INDIVIDUALIZED INFORMATION IN COST-EFFECTIVENESS ANALYSIS: WHEN IS AN OUTCOME PREDICTION MODEL WORTH USING?
• VARIABLE SELECTION FOR PROPENSITY SCORE MODELS IN COMPARATIVE EFFECTIVENESS RESEARCH ON CHRONIC CORONARY ARTERY DISEASE
• VALUE OF INDIVIDUALIZED INFORMATION IN COST-EFFECTIVENESS ANALYSIS: WHEN IS AN OUTCOME PREDICTION MODEL WORTH USING?